In Vivo & Preclinical Inhalation Studies 

Preclinical inhalation studies are a critical stage in drug development, providing the efficacy and safety data required by global regulatory agencies. These studies help establish dose–response relationships, identify potential toxicities, and demonstrate that disease models accurately reflect human conditions. High‑quality, reproducible exposure systems are essential for generating defensible data that supports regulatory submissions and accelerates therapeutic development.

Scielutions supplies advanced in vivo exposure platforms, aerosol generation systems, and monitoring technologies designed for precise, controlled inhalation studies. Our solutions support the creation of reliable disease models and the evaluation of candidate treatments, offering the scalability needed to run studies ranging from small cohorts to large‑scale regulatory programmes. Systems are engineered to deliver stable test atmospheres across a wide concentration range, including the levels required for OECD and EPA acute inhalation toxicity testing.

Working with leading global partners, Scielutions provides the tools and expertise necessary to meet the stringent standards of modern inhalation research. Our fully integrated exposure systems, generation devices, and control and monitoring technologies give laboratories the confidence to conduct high‑quality studies that meet regulatory expectations and advance therapeutic innovation.